6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Telemedicine and Office-Based Care for Behavioral and Psychiatric Conditions During the COVID-19 Pandemic in the United States

      other
      , MHS, , , MPH, , MD, PhD, , MD, MS
      Annals of Internal Medicine
      American College of Physicians

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: The coronavirus disease 2019 (COVID-19) pandemic has had far-reaching effects on health care delivery in the United States, ranging from postponement of elective care (1) to increases in the use of telemedicine (2). However, little is known about how the pandemic has affected the treatment of behavioral and psychiatric conditions. Objective: To characterize quarterly telemedicine and office-based visits from the first quarter of 2018 (2018Q1) through the second quarter of 2020 (2020Q2). Methods and Findings: We used IQVIA's National Disease and Therapeutic Index—a proprietary, 2-stage, stratified (by specialty and geographic area), nationally representative audit of ambulatory care in the United States—to characterize quarterly telemedicine and office-based visits from 2018Q1 through 2020Q2. Telemedicine visits included those taking place by telephone as well as through web-based platforms. The National Disease and Therapeutic Index involves approximately 4800 physicians who use an electronic form to record details of all patient contacts during 2 consecutive workdays per quarter and generates more than 350 000 annual contact records. Reporting days are randomly assigned to ensure that all workdays in a report period are covered; Saturdays, Sundays, and holidays are assigned as reporting days to physicians practicing on those days. We restricted our analyses to primary care and psychiatric visits and focused on care for 6 of the most prevalent behavioral and psychiatric conditions in the United States: anxiety, depression, overactivity, bipolar disorder, insomnia, and opioid use disorder (3). Total visits across settings for the 6 conditions decreased from an average of 15.9 million during the first quarter of 2018 and 2019 (2018/2019Q1) to 13.0 million in 2020Q1 (percentage change, −18%) before increasing to 15.8 million in 2020Q2, which is near the 2018/2019Q2 average of 15.7 million (Figure and Table). Office-based visits decreased from an average quarterly volume of 15.5 million before 2020 to 11.9 million in 2020Q1 and 5.3 million in 2020Q2. During the same period, telemedicine visits accounted for fewer than 3% of visits before 2020 (approximately 0.4 million), 9% during 2020Q1 (1.1 million), and 66% during 2020Q2 (10.5 million). Generally, there were no significant variations in patients' sex or race/ethnicity during the same period; however, patients who had telemedicine visits were younger, especially in 2020Q2. Most visits were subsequent rather than new visits, even after the shift to telemedicine starting in 2020 (Figure), suggesting that telemedicine served primarily to accommodate persons already established in care. Figure. Quarterly trends in telemedicine and office-based visits for behavioral and psychiatric conditions in the United States, 2018–2020 ( n = 16 067 unweighted total visits). Q = quarter. Source: IQVIA's National Disease and Therapeutic Index, 2018–2020, based on a sampling frame of more than 500 000 physicians from the American Medical Association and the American Osteopathic Association master lists. Estimates are weighted based on survey weights provided by the National Disease and Therapeutic Index. Conditions were defined on the basis of having International Classification of Diseases, Ninth Revision codes listed from a visit. Data were based on primary care (family practice, general practice, geriatrics, internal medicine, and pediatrics) and psychiatrist visits. Figure. Quarterly trends in telemedicine and office-based visits for behavioral and psychiatric conditions in the United States, 2018–2020 ( n = 16 067 unweighted total visits). Q = quarter. Source: IQVIA's National Disease and Therapeutic Index, 2018–2020, based on a sampling frame of more than 500 000 physicians from the American Medical Association and the American Osteopathic Association master lists. Estimates are weighted based on survey weights provided by the National Disease and Therapeutic Index. Conditions were defined on the basis of having International Classification of Diseases, Ninth Revision codes listed from a visit. Data were based on primary care (family practice, general practice, geriatrics, internal medicine, and pediatrics) and psychiatrist visits. Table. Telemedicine and Office-Based Visits for Behavioral and Psychiatric Conditions in the United States During the First Two Quarters of 2018–2020 (n = 9540 Unweighted Total Visits)* Table. Telemedicine and Office-Based Visits for Behavioral and Psychiatric Conditions in the United States During the First Two Quarters of 2018–2020 (n = 9540 Unweighted Total Visits)* From 2018/2019Q1 to 2020Q1, there were decreases of 17% to 31% in office-based visits across the 6 conditions (Figure and Table). Office-based visits decreased further, by 49% (opioid use disorder) to 73% (bipolar disorder), between 2018/2019Q2 and 2020Q2. By contrast, telemedicine visits increased by 55% (bipolar disorder) to 360% (overactivity) between 2018/2019Q1 and 2020Q1 and by 1620% (insomnia) to 8061% (overactivity) between 2018/2019Q2 and 2020Q2. Discussion: The COVID-19 pandemic has been associated with large decreases in office-based visits for behavioral and psychiatric conditions, although by 2020Q2 these had been offset by large increases in telemedicine visits among the conditions examined. Given concerns about the potential deleterious effects of the pandemic on the behavioral and psychiatric needs of vulnerable populations as well as the implementation of policies to mitigate such harms (4), the increases in telemedicine visits are noteworthy. However, further work is needed to establish how effectively telemedicine can reduce logistic and social barriers to mental health care. It is also unclear if the increases we note are sufficient to address the increased prevalence of depressive and anxiety symptoms as a result of the COVID-19 pandemic (5). Despite our analyses' insights, they provide a snapshot of dynamic processes and, like all surveys, may be prone to measurement error and bias. These limitations notwithstanding, our findings suggest profound shifts in care patterns for common behavioral and psychiatric illnesses in the United States and underscore the importance of further work to assess how different treatment settings, including the delivery of care through telemedicine platforms, may affect patients' experiences and health outcomes.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

          Key Points Question Is there a quantifiable association between the coronavirus disease 2019 (COVID-19) pandemic and the volume, type, and content of primary care encounters in the US? Findings In this cross-sectional analysis of the US National Disease and Therapeutic Index audit of more than 125.8 million primary care visits in the 10 calendar quarters between quarter 1 of 2018 and quarter 2 of 2020, primary care visits decreased by 21.4% during the second quarter of 2020 compared with the average quarterly visit volume of the second quarters of 2018 and 2019. Evaluations of blood pressure and cholesterol levels decreased owing to fewer total visits and less frequent assessment during telemedicine encounters. Meaning The COVID-19 pandemic was associated with changes in the structure of primary care delivery during the second quarter of 2020, with the content of telemedicine visits differing from that of office-based encounters.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19

            The COVID-19 pandemic is a particularly grave risk to the millions of Americans with opioid use disorder, who—already vulnerable and marginalized—are heavily dependent on face-to-face health care delivery. These authors propose rapid and coordinated action on the part of clinicians and policymakers to mitigate risks of disrupted care for these patients.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health: Current Risks and Recommended Actions

                Bookmark

                Author and article information

                Journal
                Ann Intern Med
                Ann Intern Med
                aim
                Annals of Internal Medicine
                American College of Physicians
                0003-4819
                1539-3704
                17 November 2020
                : M20-6243
                Affiliations
                [1 ]Monument Analytics, Baltimore, Maryland (O.M.)
                [2 ]Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.T., J.H., R.M.)
                [3 ]Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, and Johns Hopkins Medicine, Baltimore, Maryland (G.C.A.)
                Author notes
                Reproducible Research Statement: Study protocol and data set: Not available. Statistical code: Available from Dr. Alexander (e-mail, galexan9@ 123456jhmi.edu ).
                Corresponding Author: G. Caleb Alexander, MD, MS, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, W6035, Baltimore, MD 21205; e-mail, galexan9@ 123456jhmi.edu .
                Author information
                https://orcid.org/0000-0003-1372-3526
                https://orcid.org/0000-0003-1375-9510
                https://orcid.org/0000-0002-2134-4043
                https://orcid.org/0000-0002-5622-2986
                Article
                aim-olf-M206243
                10.7326/M20-6243
                7711651
                33197214
                bbcd9efd-feba-4177-80ec-d0503e5b5d28
                Copyright @ 2020

                This article is made available via the PMC Open Access Subset for unrestricted re-use for research, analyses, and text and data mining through PubMed Central. Acknowledgement of the original source shall include a notice similar to the following: "© 2020 American College of Physicians. Some rights reserved. This work permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited." These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Categories
                Letters
                Observations: Brief Research Reports
                early, Currently Online First
                coronavirus, Coronavirus Disease 2019 (COVID-19)
                hvc, High-Value Care
                3122457, COVID-19
                2357, Health care providers
                11279, SARS coronavirus
                9715, Patients
                6354, Upper respiratory tract infections
                1541398, Pulmonary diseases
                3282, Infectious diseases
                8910, Epidemiology
                7245, Lungs

                Comments

                Comment on this article